Thalidomide: Still an important second-line treatment in refractory cutaneous lupus erythematosus?

Abstract

Because of high risk of polyneuropathy, low-dose thalidomide should be used and long-term therapy should be avoided. Therefore, it should be recommended to combine thalidomide with other treatments for CLE.